Literature DB >> 31363044

The buffering capacity of the brain and optic nerve against spaceflight-associated neuro-ocular syndrome.

Peter Wostyn1, Thomas H Mader2, Charles Robert Gibson3, Peter Paul De Deyn4,5,6,7.   

Abstract

Entities:  

Year:  2019        PMID： 31363044      PMCID： PMC6689895          DOI： 10.1073/pnas.1908865116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  8 in total

1.  Asymmetric Papilledema in Idiopathic Intracranial Hypertension: Comment.

Authors:  Thomas H Mader; C Robert Gibson; Stephen F Hart; Andrew G Lee
Journal:  J Neuroophthalmol       Date:  2016-03       Impact factor: 3.042

2.  Asymmetric Papilledema in Idiopathic Intracranial Hypertension: Comment.

Authors:  Hanspeter E Killer
Journal:  J Neuroophthalmol       Date:  2015-09       Impact factor: 3.042

Review 3.  Intracranial pressure-induced optic nerve sheath response as a predictive biomarker for optic disc edema in astronauts.

Authors:  Peter Wostyn; Peter Paul De Deyn
Journal:  Biomark Med       Date:  2017-09-04       Impact factor: 2.851

4.  Optic Nerve Sheath Distention as a Protective Mechanism Against the Visual Impairment and Intracranial Pressure Syndrome in Astronauts.

Authors:  Peter Wostyn; Peter Paul De Deyn
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-09-01       Impact factor: 4.799

Review 5.  The escape of retrobulbar cerebrospinal fluid in the astronaut's eye: mission impossible?

Authors:  Peter Wostyn; Thomas H Mader; Charles Robert Gibson; Hanspeter Esriel Killer
Journal:  Eye (Lond)       Date:  2019-05-07       Impact factor: 3.775

6.  Asymmetric papilledema in idiopathic intracranial hypertension.

Authors:  Samuel Bidot; Beau B Bruce; Amit M Saindane; Nancy J Newman; Valérie Biousse
Journal:  J Neuroophthalmol       Date:  2015-03       Impact factor: 3.042

7.  The Optic Canal Size Is Associated With the Severity of Papilledema and Poor Visual Function in Idiopathic Intracranial Hypertension.

Authors:  Samuel Bidot; Lindsay Clough; Amit M Saindane; Nancy J Newman; Valérie Biousse; Beau B Bruce
Journal:  J Neuroophthalmol       Date:  2016-06       Impact factor: 3.042

8.  Brain ventricular volume changes induced by long-duration spaceflight.

Authors:  Angelique Van Ombergen; Steven Jillings; Ben Jeurissen; Elena Tomilovskaya; Alena Rumshiskaya; Liudmila Litvinova; Inna Nosikova; Ekaterina Pechenkova; Ilya Rukavishnikov; Olga Manko; Sergey Danylichev; R Maxine Rühl; Inessa B Kozlovskaya; Stefan Sunaert; Paul M Parizel; Valentin Sinitsyn; Steven Laureys; Jan Sijbers; Peter Zu Eulenburg; Floris L Wuyts
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-06       Impact factor: 11.205
  8 in total
  4 in total

1.  Reply to Wostyn et al.: Investigating the spaceflight-associated neuro-ocular syndrome and the human brain in lockstep.

Authors:  Angelique Van Ombergen; Steven Jillings; Elena Tomilovskaya; Floris L Wuyts; Peter Zu Eulenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-30       Impact factor: 11.205

2.  Persistent Globe Flattening in Astronauts following Long-Duration Spaceflight.

Authors:  Thomas H Mader; C Robert Gibson; Michael R Barratt; Neil R Miller; Prem S Subramanian; Hanspeter E Killer; William J Tarver; Ashot E Sargsyan; Kathleen Garcia; Stephen F Hart; Larry A Kramer; Roy Riascos; Tyson J Brunstetter; William Lipsky; Peter Wostyn; Andrew G Lee
Journal:  Neuroophthalmology       Date:  2020-09-03

Review 3.  A review of alterations to the brain during spaceflight and the potential relevance to crew in long-duration space exploration.

Authors:  Meaghan Roy-O'Reilly; Ajitkumar Mulavara; Thomas Williams
Journal:  NPJ Microgravity       Date:  2021-02-16       Impact factor: 4.415

Review 4.  Does Long-Duration Exposure to Microgravity Lead to Dysregulation of the Brain and Ocular Glymphatic Systems?

Authors:  Peter Wostyn; Thomas H Mader; Charles Robert Gibson; Maiken Nedergaard
Journal:  Eye Brain       Date:  2022-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.